NCT02980510View on ClinicalTrials.gov

Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil

DRUG

Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan

Trial Locations (6)

Unknown

Institut Sainte Catherine, Avignon

Centre Léon Berard, Lyon

Chu Saint Eloi, Montpellier

ICM Val D'Aurelle, Montpellier

Institut de Cancérologie de Lorraine, Nancy

CHU Carémeau - Institut de Cancérologie du Gard, Nîmes

All Listed Sponsors
lead

UNICANCER

OTHER